Adebrelimab Clinical Trials
44 recruitingDrug
Phase 236Phase 110Phase 32Not Applicable2
Showing 1–20 of 44 trials
Recruiting
Phase 1Phase 2
Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer
Advanced Biliary Tract Carcinoma
Tongji Hospital29 enrolled1 locationNCT07392541
Recruiting
Phase 2
Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study
Esophageal Squamous Cell Carcinoma
The Affiliated Hospital of Putian University42 enrolled1 locationNCT07437898
Recruiting
Phase 2
Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
Small Cell Lung Cancer Extensive Stage
Sichuan University202 enrolled1 locationNCT06610734
Recruiting
Phase 2
Adebrelimab, Apatinib & SOX for Conversion Therapy in Advanced Gastric/GEJ Cancer
AdebrelimabAdenocarcinoma of GE JunctionAdenocarcinoma of Stomach
Beijing Friendship Hospital49 enrolled1 locationNCT07353684
Recruiting
Phase 2
Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy
Stomach Neoplasms
Shandong Tumor Hospital66 enrolled1 locationNCT07309185
Recruiting
Phase 2
Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)
Urothelial CarcinomaAdvanced Urothelial CarcinomaUrothelial Carcinoma Recurrent
Sun Yat-sen University96 enrolled5 locationsNCT07241793
Recruiting
Phase 2
Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma
Bladder CancerNeuroendocrine Carcinoma of the Bladder
RenJi Hospital22 enrolled5 locationsNCT06091124
Recruiting
Phase 2
A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.300 enrolled1 locationNCT07229729
Recruiting
Phase 1Phase 2
A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.96 enrolled2 locationsNCT07059221
Recruiting
Phase 2
Single-Arm Exploratory Study of PD-L1 Antibody Plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
Squamous Cell Carcinoma of Head and Neck
Xiuping Ding69 enrolled1 locationNCT07055841
Recruiting
Not Applicable
Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma
Nanjing Tianyinshan Hospital300 enrolled1 locationNCT06893887
Recruiting
Phase 2
The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell Carcinoma
Clinical IVb Stage Oral Squamous Cell Carcinomas Patients
Hospital of Stomatology, Wuhan University35 enrolled1 locationNCT06277791
Recruiting
Phase 3
Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.590 enrolled1 locationNCT06618664
Recruiting
Phase 2
A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer
Small Cell Lung Cancer Limited Stage
Jin Ying38 enrolled1 locationNCT06483282
Recruiting
Phase 2
Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
Intrahepatic Cholangiocarcinoma
The First Affiliated Hospital with Nanjing Medical University33 enrolled3 locationsNCT06208462
Recruiting
Not Applicable
Second-line Immunotherapy for ES-SCLC
Tianjin Medical University Cancer Institute and Hospital30 enrolled1 locationNCT06853678
Recruiting
Phase 2
Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
Colorectal Cancer Metastatic
The Fourth Affiliated Hospital of Zhejiang University School of Medicine36 enrolled1 locationNCT06282445
Recruiting
Phase 2
Adebrelimab With or Without SHR-8068 in Combination With Cisplatin Plus Gemcitabine as First-line Treatment in Patients With Advanced Biliary Tract Cancer
Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.80 enrolled1 locationNCT06465563
Recruiting
Phase 2
Adebrelimab and Chemoradiotherapy in High-risk LANPC
Nasopharyngeal CancerNasopharyngeal Carcinoma
Sun Yat-sen University50 enrolled4 locationsNCT06349889
Recruiting
Phase 1Phase 2
A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer
Gastric Cancer
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center52 enrolled1 locationNCT06776770